Tulmimetostat

SKU: orb1690766

Description

Tulmimetostat (CPI-0209) is an oral EZH1/EZH2 inhibitor with demonstrated antitumor activity. It is utilized in preclinical research for ovarian cancer and advanced solid tumors, showing efficacy in both in vitro cellular assays and in vivo animal models.

Research Area

Epigenetics & Chromatin

Key Properties

• CAS Number: 2567686-02-4
• MW: 562.12
• Purity: 99.87% (May vary between batches)
• Formula: C₂₈H₃₆ClN₃O₅S
• SMILES: CC1=C2C(O[C@@](C)(O2)[C@@]3(CC[C@H](CC3)N4CC(OC)C4)[H])=C(Cl)C=C1C(NCC5=C(SC)C=C(C)NC5=O)=O
• Target: Histone Methyltransferase
• Solubility: DMSO:140 mg/mL (249.06 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.56 mM)

Storage & Handling

• Storage: store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

CPI-0209, CPI0209, CPI 0209, Histone Methyltransferase, HistoneMethyltransferase, EZH2, EZH1, Tulmimetostat

Compound Identifiers

PubChem CID

155590998